JP2017019841A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017019841A5 JP2017019841A5 JP2016174646A JP2016174646A JP2017019841A5 JP 2017019841 A5 JP2017019841 A5 JP 2017019841A5 JP 2016174646 A JP2016174646 A JP 2016174646A JP 2016174646 A JP2016174646 A JP 2016174646A JP 2017019841 A5 JP2017019841 A5 JP 2017019841A5
- Authority
- JP
- Japan
- Prior art keywords
- maintenance
- improvement
- qol
- improving
- maintaining
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2011080814 | 2011-03-31 | ||
| JP2011080814 | 2011-03-31 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013507674A Division JP6061842B2 (ja) | 2011-03-31 | 2012-03-28 | Ｑｏｌ改善又は持続剤 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017019841A JP2017019841A (ja) | 2017-01-26 |
| JP2017019841A5 true JP2017019841A5 (enExample) | 2017-03-16 |
| JP6261688B2 JP6261688B2 (ja) | 2018-01-17 |
Family
ID=46931242
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013507674A Active JP6061842B2 (ja) | 2011-03-31 | 2012-03-28 | Ｑｏｌ改善又は持続剤 |
| JP2016174646A Active JP6261688B2 (ja) | 2011-03-31 | 2016-09-07 | Ｑｏｌ改善又は持続剤 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013507674A Active JP6061842B2 (ja) | 2011-03-31 | 2012-03-28 | Ｑｏｌ改善又は持続剤 |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US9623054B2 (enExample) |
| EP (1) | EP2692349B1 (enExample) |
| JP (2) | JP6061842B2 (enExample) |
| KR (1) | KR101878525B1 (enExample) |
| CN (1) | CN103458905A (enExample) |
| AU (1) | AU2012233590B2 (enExample) |
| CA (1) | CA2831554C (enExample) |
| ES (1) | ES2617989T3 (enExample) |
| PH (1) | PH12013501951A1 (enExample) |
| SG (3) | SG193508A1 (enExample) |
| TW (1) | TWI642363B (enExample) |
| WO (1) | WO2012133533A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108495558A (zh) * | 2016-04-20 | 2018-09-04 | 株式会社明治 | 疲劳感改善用发酵乳 |
| TWI583388B (zh) * | 2016-08-24 | 2017-05-21 | 國立體育大學 | 胚芽乳酸桿菌用於製備改善運動表現及降低肌肉疲勞之益生菌組合物之用途 |
| JP7535040B2 (ja) * | 2019-06-03 | 2024-08-15 | アサヒグループホールディングス株式会社 | 歩行能力改善剤 |
| JP7593740B2 (ja) * | 2020-03-02 | 2024-12-03 | 株式会社明治 | 睡眠の質改善用組成物、全体的健康感改善用組成物および活力向上用組成物 |
| JP7703165B2 (ja) * | 2020-07-27 | 2025-07-07 | 独立行政法人国立病院機構 | Ｑｏｌ改善剤 |
| TW202442251A (zh) * | 2023-04-12 | 2024-11-01 | 葡萄王生技股份有限公司 | 抗疲勞乳酸菌組成物及其用途 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004112809A1 (ja) * | 2003-06-24 | 2004-12-29 | Otsuka Pharmaceutical Co., Ltd. | 血清尿酸低減組成物 |
| US7842495B2 (en) | 2003-08-21 | 2010-11-30 | Otsuka Pharmaceutical Co., Ltd. | Lactic acid bacteria capable of stimulating mucosal immunity |
| US8182849B2 (en) | 2005-02-23 | 2012-05-22 | Otsuka Pharmaceutical Co., Ltd. | Fermented tea beverage and tea beverage |
| JP5467785B2 (ja) * | 2009-03-25 | 2014-04-09 | 大塚製薬株式会社 | 抗鳥インフルエンザウイルス抗体の産生促進剤 |
-
2012
- 2012-03-28 US US14/008,325 patent/US9623054B2/en active Active
- 2012-03-28 SG SG2013069984A patent/SG193508A1/en unknown
- 2012-03-28 SG SG10201602487SA patent/SG10201602487SA/en unknown
- 2012-03-28 KR KR1020137028373A patent/KR101878525B1/ko active Active
- 2012-03-28 JP JP2013507674A patent/JP6061842B2/ja active Active
- 2012-03-28 SG SG10201912606QA patent/SG10201912606QA/en unknown
- 2012-03-28 ES ES12762904.6T patent/ES2617989T3/es active Active
- 2012-03-28 PH PH1/2013/501951A patent/PH12013501951A1/en unknown
- 2012-03-28 EP EP12762904.6A patent/EP2692349B1/en active Active
- 2012-03-28 CA CA2831554A patent/CA2831554C/en active Active
- 2012-03-28 CN CN2012800144844A patent/CN103458905A/zh active Pending
- 2012-03-28 AU AU2012233590A patent/AU2012233590B2/en active Active
- 2012-03-28 WO PCT/JP2012/058145 patent/WO2012133533A1/ja not_active Ceased
- 2012-03-29 TW TW101111098A patent/TWI642363B/zh active
-
2016
- 2016-09-07 JP JP2016174646A patent/JP6261688B2/ja active Active
-
2017
- 2017-04-17 US US15/488,623 patent/US10369177B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Latta | Letter from Dr. Latta to the Secretary of the Central Board of Health, London, affording a view of the rationale and results of his practice in the treatment of cholera by aqueous and saline injections. 1832 | |
| UY31305A1 (es) | Derivados de 1,2,4,5-tetrahidro-3h-benzazepinas, su procedimiento de preparacion y las composiciones farmacéuticas que las contienen. | |
| CO6771406A2 (es) | Una composición combinada | |
| JP2020536085A5 (enExample) | ||
| MX2018008709A (es) | Uso terapeutico de inhibidores de activacion o estimulacion de celulas t. | |
| CL2016000160A1 (es) | Pelicula oral que comprende hidroxipropilcelulosa sola o combinada con polivinilpirrolidona, al menos un copolímero de vinilpirrolidona, dioxido de titanio, en donde la relación del copolímero de vinilpirrolidona con el dioxido de titanio es de 3 es a 1 a 5 es a 1, y rizatriptán, zolmitriptán, alprazolam, diazepam o lorazepam, como principio activo. | |
| PH12018500315A1 (en) | Fumagillol heterocyclic compounds and methods of making and using same | |
| JP2018035153A5 (enExample) | ||
| EP4631569A3 (en) | Alginate film comprising a triptan | |
| WO2016074641A8 (zh) | Nadh或其盐在制备治疗苯丙酮尿症药物或保健品的应用 | |
| EA202191106A1 (ru) | Пробиотическая добавка для метаболического здоровья, содержащая lactobacillus | |
| GB0606848D0 (en) | Product, method of manufacture and use | |
| JP2016175884A5 (enExample) | ||
| CN205321959U (zh) | 一种养生型水果盘 | |
| WO2016027225A8 (en) | A composition having a muscle-relaxant and anti-inflammatory activity | |
| MX2025002392A (es) | Formulaciones de dantroleno y metodos de uso de dichas formulaciones | |
| JP2014240383A5 (enExample) | ||
| Komine et al. | Study on the problem and the effect when a handicapped person made furniture. The proposal of the Habilitation Chair. | |
| JP2017137280A (ja) | 全身ｔテロメア１００％保持ゲノム創薬 | |
| CN302570663S (zh) | 电极 | |
| Moreno | Sustained ventricular fibrillation: case report | |
| Bauman et al. | Misophonia Physiological Response Scale (MPRS) | |
| ZA202102913B (en) | Dosage regime | |
| 주인옥 | Epistemic-Ontic Circle for Self-Actualization in Faith Community | |
| 福山美季 et al. | Factors influencing the decision-making of elderly acute leukemia patients in Japan regarding their treatment |